Search for: "General Motors Acceptance Corp. v. United States" Results 101 - 120 of 151
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2012, 5:05 pm by support
” The auto alliance includes General Motors Co., Ford Motor Co., Chrysler Group LLC, Toyota and eight others. [read post]
25 Apr 2015, 11:03 am by Schachtman
Third, the Manual authors state that the doubling argument assumes the “[n]onacceleration of disease. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property Watch),… [read post]
26 Feb 2011, 3:47 pm
Cir. 1996) ("The nonobviousness of the accused device, evidenced by the grant of a United States patent, is relevant to the issue of whether the change therein is substantial. [read post]
30 Jun 2015, 6:52 am by Schachtman
The discovery obligations with respect to statistician expert witnesses vary considerably among state and federal courts. [read post]
9 Aug 2018, 6:21 pm by Wolfgang Demino
She argues that they "fraudulently informed [her] that the [d]ebts were not discharged and demanded . . . and accepted payment. [read post]
18 Mar 2010, 2:47 pm by Beck, et al.
General Motors Corp., 463 F.2d 98, 100 (2d Cir. 1972) (“bare bones statement. . .without any supporting facts permits dismissal”); Jackson v. [read post]
15 Mar 2010, 2:09 pm by Robinson, Calcagnie & Robinson
In the process, these changes have saved lives here in the United States and abroad, and prevented countless injuries. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
6 Sep 2018, 8:03 am by Joy Waltemath
Although August is not typically a hotbed of Supreme Court activity, this month a 16-state coalition of attorneys general has urged the High Court to take up whether Title VII protects employees from discrimination based on transgender status. [read post]